Chairman of the Board
Dennis Condon is currently a member of the Audit and Risk Committee and the Remuneration and Nomination Committee, as well as CEO and President of Nuvesse Skin Therapies, a venture-backed cosmeceutical skincare company that has launched 12 products into the US medical device market. He was formerly CEO and President of Merz Aesthetics, Inc. (from September 2011 to January 2013), after serving as President and Chief Business Officer from July 2007 and a board member from 2004 to 2007. Additionally, Mr. Condon was the former CEO of BioForm Medical (acquired by Merz Aesthetic for US$250 million).
Mr. Condon carries 30 years of experience in key executive roles in the plastic surgery market, including serving as the President and CEO of Mentor Aesthetics, one of the two largest global breast implant manufacturers.
Ron Eastman is a Managing Director at EW Healthcare Partners (formerly Essex Woodlands) in Palo Alto, CA. Having over 35 years of experience in building healthcare businesses, Ron began his career at American Cyanamid Company. There he managed pharmaceutical products, divisions and subsidiaries in the U.S. and overseas, and has since helped build three private healthcare companies—Geron, HCORP, and Rinat Neuroscience.
Under his leadership, Geron became a cutting-edge biotech company growing from a venture-backed startup to a publicly traded pioneer in regenerative medicine and cancer treatment. HCORP established itself as the leader in hospital-based, interactive patient services, and was sold to a diversified competitor. At Rinat, Ron led the effort to build the first company dedicated to discovering and developing large molecule drugs for treating nervous system disorders. Rinat was acquired by Pfizer for $500 million in 2006.
Mr. Eastman serves on the boards of Corium International, EluSys Therapeutics, Inc. and IntegenX Inc.
Brian Chee is a general partner of Polaris Partners, with a primary focus on investments in healthcare and technology companies. Mr. Chee’s vast board experience incorporates currently serving on the boards of Bohola, Data Sciences, Ella Health, Medvantx, and US HealthVest. Mr. Chee received his M.B.A. from the Tuck School of Business at Dartmouth, and his B.S. from the U.S. Military Academy at West Point. Prior to joining Polaris in 1996, Mr. Chee attained significant business operations and leadership expertise with Baxter Healthcare, a global, diversified healthcare company with expertise in medical devices, pharmaceuticals and biotechnology.
CHIEF EXECUTIVE OFFICER
Pat Altavilla joined Suneva Medical in October 2016 as Vice President of Sales and Marketing after a distinguished 30-year career in the aesthetics and medical fields. Early in her career Altavilla served as vice president of international sales and worldwide marketing for Mentor Corporation, where for nearly 20 years she helped the company grow sales tenfold, launch new products, and enhance its global market presence and sales training. Altavilla then worked as vice president of sales, marketing and operations officer at The Plastic Surgery Company, and co-founded and ran Spa Medicu/Medicus Skin Enhancement for several years, before returning to a corporate executive position with BioForm Medical. Altavilla served most notably as vice president of global marketing where she was instrumental in restructuring marketing, growing sales, creating a practice development program and raising the company’s overall visibility in the marketplace. Most recently, Altavilla worked for medical technology company ZELTIQ® Aesthetics Inc. where she served in numerous leadership roles. Altavilla was instrumental in developing the brand’s global marketing organization as well as growing physician loyalty, enhancing practice development, launching innovative products, and increasing the company’s presence.
Vince Ippolito has over 30 years of experience in the pharmaceuticals industry, including 20 years in dermatology and aesthetic medicine. He most recently served as the Chief Commercial Officer Executive Vice President of Anacor Pharmaceuticals until Sept 2017, where he was responsible for developing marketing and sales functions, as well as strategizing the company’s product portfolio. Previously, Mr. Ippolito was Executive Vice President and Chief Commercial Officer at Medicis, a leading dermatology and aesthetic medicine company, who brought Restylane and Dysport to Market in the US. Throughout his career, he has launched more than 20 brands in dermatology and aesthetic medicine. He took a leading role in two of the largest dermatology acquisitions in the past five years totaling $7.8 billion.
Mr. Ippolito holds a B.A. in Business Administration, Management, and Operations from the University of Wisconsin and a minor in East Asian Studies from Sophia University in Japan.